Buprenorphine

Administer buprenorphine sublingual tablets sublingually as a single daily dose. Strongly consider recommending or prescribing an opioid overdose reversal agent (e.g., naloxone, nalmefene) at the time buprenorphine sublingual tablets are initiated or renewed because patients being treated for opioid use disorder have the potential for relapse, putting them at risk for opioid overdose. To avoid precipitating withdrawal, induction with buprenorphine sublingual tablets should be undertaken when objective and clear signs of withdrawal are evident.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Buprenorphine sublingual tablets are contraindicated in patients with a history of hypersensitivity to buprenorphine, as serious adverse reactions, including anaphylactic shock, have been reported. Hypersensitivity to buprenorphine.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Addiction, Abuse, and Misuse: Buprenorphine can be abused in a similar manner to other opioids. Monitor patients for conditions indicative of diversion or progression of opioid dependence and addictive behaviors. Multiple refills should not be prescribed early in treatment or without appropriate patient follow-up visits. Respiratory Depression: Life-threatening respiratory depression and death have occurred in association with buprenorphine use. Warn patients of the potential danger of self-administration of benzodiazepines or other CNS depressants while under treatment with buprenorphine sublingual tablets.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are described elsewhere in the labeling: Addiction, Abuse, and Misuse Respiratory and CNS Depression Neonatal Opioid Withdrawal Syndrome Adrenal Insufficiency Opioid Withdrawal Hepatitis, Hepatic Events Hypersensitivity Reactions Orthostatic Hypotension Elevation of Cerebrospinal Fluid Pressure Elevation of Intracholedochal Pressure Adverse events commonly observed with administration…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

32 products from 15 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 32 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store at 25°C (77°F);

Storage information from the U.S. FDA-approved label.